Comparison of the tolerability, ease of use, and efficacy of donepezil and rivastigmine in Alzheimer's disease patients: A 12-week multinational study

被引：0
|
作者：
Wilkinson, DG
Passmore, P
Smith, R
Hock, C
Potonik, F
Maud, C
Hopker, S
机构：
来源：
NEUROLOGY | 2001年 / 56卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A456 / A457
页数：2
相关论文
共 50 条
  • [41] Efficacy and tolerability of ziprasidone in acute bipolar mania: 12-week double-blind study
    Ramey, TS
    Giller, EL
    English, P
    Riesenberg, R
    Trivedi, JK
    Avedisova, AS
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 53S - 53S
  • [42] Efficacy and tolerability of ziprasidone in acute bipolar mania: 12-week, double-blind study
    Dunn, J
    Ramey, T
    Giller, F
    English, P
    Riesenberg, R
    Trivedi, J
    Tochilov, V
    EUROPEAN PSYCHIATRY, 2005, 20 : S128 - S128
  • [43] Efficacy of Rivastigmine on cognitive and behavioral symptoms in patients with Alzheimer's disease
    Baloescu, A
    Tudor, C
    Vasile, D
    Ciurea, R
    Gheorghe, MD
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S58 - S58
  • [44] Safety and tolerability of rivastigmine capsules plus memantine in patients with probable Alzheimer's disease
    Brannan, Stephen
    Koumaras, Barbara
    Figiel, Gary
    Farlow, Martin
    ANNALS OF NEUROLOGY, 2008, 64 : S40 - S41
  • [45] A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease
    Nakamura, Yu
    Strohmaier, Christine
    Tamura, Kaoru
    Kataoka, Naoko
    Nakano, Masayuki
    Oda, Shoichiro
    Nishimura, Kazuma
    Homma, Akira
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2015, 5 (03): : 361 - 374
  • [46] Safety and tolerability of high dose donepezil in patients with Alzheimer's disease: A preliminary report of a pilot study
    Shua-Haim, JR
    Pass, M
    Patel, S
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 357
  • [47] Comparison of combination therapy with rivastigmine (Exelon) and donepezil (Aricept) versus rivastigmine alone for treatment of Alzheimer's disease: Safety, tolerability and clinical experience after one year of treatment (a cross-sectional study)
    Shua-Haim, J
    Smith, J
    Amin, S
    Shua-Haim, V
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S76 - S77
  • [48] Results of one-week overlap-crossover study of donepezil (aricept) to rivastigmine (exelon) in Alzheimer's disease patients: A one-month prospective study.
    Shua-Haim, JR
    Smith, JM
    Amin, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S76 - S76
  • [49] Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study
    Tsuno, Norifumi
    Mori, Takahiro
    Ishikawa, Ichiro
    Bando, Nobuyasu
    Park, Haeyoung
    Matsumoto, Yoshito
    Mori, Itsuko
    Tanaka, Mariko
    Hirano, Takayuki
    Nakamura, Yu
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (07) : 571 - 576
  • [50] Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis
    Hansen, Richard A.
    Gartlehner, Gerald
    Webb, Aaron P.
    Morgan, Laura C.
    Moore, Charity G.
    Jonas, Daniel E.
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 211 - 225
12345